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Abstract
Aim of the work. The study of interconnection between atherogenic parameters of the blood serum and cardiac indices 
during pregnancy with the risk of pre-eclampsia development and prognostication of remote cardio-vascular and/or metabolic pa-
thology among pregnant. 
Materials and methods. The indices of lipid metabolism in the blood serum of 267 pregnant women were studied using di-
agnostic sets of reagents. The blood sampling was carried out in II (16–24 gestational weeks) trimester. The general cholesterol (GC) 
and triglycerides (TG) were determined by colorimetric and enzymatic method; high-density lipoproteins – HDL – by homogenous 
method of direct determination of HDL-cholesterol concentration in the blood serum without preliminary processing and centrifuga-
tion, low-density lipoproteins – LDL – by the direct method. VLDL concentration was calculated by Friedewald formula: LDL=TG/2,2. 
For evaluation of GC-VLDL concentration TG/2,2 parameter is used, if TG concentration is expressed in mmol/l (or TG/5, if 
concentration is expressed in mg/100 ml). 
Cardiac indices were calculated taking into account the lipid parameters according to the correspondent mathematical formulas. 
Lactate and LDH concentrations were determined by optimized method using diagnostic reagents. Lactate concentration was deter-
mined at the use of diagnostic set for determination of lactate concentration, and DLH was also determined by diagnostic set for deter-
mination of LDH (DL) activity by optimized method, elaborated taking into account the recommendations of German Association of 
clinical chemistry (DGKC) after correspondent calibration of automatic analyzer ACCENT-200 II GEN. Depending on the development 
of clinical presentation of PE 43 women were divided in groups with light and middle severity of course of this pathology. 
Results and discussion. Among the women with PE development was observed the essential changes in II trimester in 
the aspect of atherogenic parameters and cardiac indices mainly at the expense of progressing increase of TG in the blood serum 
(mmol/l: I group – 1,73±0,14, II group – 1,86±0,18 comparing with III control group – 1,51±0,06. The gradual growth of cardiac (ath-
erogenic) indices – AIP, CR and CА and connection between AIP and the levels of maternal serumal TG and arterial pressure were 
observed in women with PE development at the absence of such connection among the women of control group (p<0,05). LDH level 
grew with the progressing of PE severity: for the women of I group LDH level was – 389±1,6 U/l at 778±0,25 in women of II group 
and 265±0,19 in the control group (p <0,05).
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Conclusions. It was demonstrated, that hypertriglyceridemia at pregnancy is a predicator relative to PE development and 
together with progressive growth of atherogenic indices can be considered as prognostic factor for cardiometabolic pathology, espe-
cially in women with undergone severe forms of this pathology. It was established, that the increase of LDH level since the second 
trimester can also testify to the development of PE and remote cardiac pathology in this category of women. 
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1. Introduction
The pathology of cardio-vascular system remains the one of main causes of morbidity and 
mortality throughout the world and especially in Ukraine. For today hypertensive disorders com-
plicate the course of 9–25 % of all pregnancies and are considered as an important risk factor of 
CVD in women [1]. The special importance is gained by pre-eclampsia (PE) that is responsible for 
each third case of obstetric morbidity, for fivefold increase of perinatal mortality and minimum for 
76 000 maternal deaths annually throughout the world [2]. PE complicates 12–17 % of pregnan-
cies and is characterized with numerous injuries that include proteinuria, thrombocytopenia, renal 
failure, disorder of liver function with edema of lungs and brain, visual symptoms, but the most 
typical is the development of arterial hypertension (systolic arterial pressure ≥140/diastolic arterial 
pressure ≥90 mm of m. c.) after the twentieth week of gestation (American college of Obstetricians 
and Gynecologists, 2013) [3]. It is important to note, that this pathology increases the risks of car-
dio-vascular pathology in future from two to four times [4]. According to the recommendations of 
American cardiologic association, since 2011 it is used to consider PE as independent gender-specif-
ic risk factor [5]. In this connection the search for early predicators of its development with possi-
ble elaboration of distinct prophylactic and treating arrangements on the base of these data remains 
topical for this time [6]. Endothelial dysfunction plays the central role in genesis of multisystem 
disorders that precede the development of PE clinical presentation. The mechanisms, involved in 
induction of endothelial cellular dysfunction are insufficiently studied for today. Today in foreign 
scientific community take place the researches, directed on confirmation or confutation of the 
possible participation of atherogenic parameters of lipid metabolism in PE pathogenesis and their 
important role for its early prognostication and diagnostics. At the same time the determination of 
several lipoprotein ratios or atherogenic (cardiac) indices [7] that can be the better alternative to the 
routine method of examination remain important in optimization of prognostic importance of lipid 
profile in genesis of remote cardio-vascular and metabolic risks after PEВ. But the scientific views 
are contradictive and include insufficiently studied aspects and this fact, undoubtedly, indicates the 
actuality of further studies in this field. 
2. Aim
The study of interconnection between atherogenic parameters of the blood serum and car-
diac indices during pregnancy with the risk of pre-eclampsia development and prognostication of 
remote cardio-vascular and/or metabolic pathology among pregnant.
3. Materials and methods
According to the set aim of research, atherogenic parameters were studied in the blood 
serum of 267 pregnant women using diagnostic set of reagents by PZ CORMAY S. A. (Poland) 
after correspondent calibration of each method on automatic analyzer ACCENT-200 II GEN. The 
blood sampling was carried out in II (16–24 gestational weeks) trimester. Criteria of inclusion: 
age 19–40 years, pregnancy with one living fruit that occurred without additional reproductive 
technologies usage, informed consent for the research during whole period of gestation, absence 
of severe somatic pathology. Criteria of exclusion from the research: the high risk of PE develop-
ment; many-fruit pregnancy, fetal anomalies and abnormal karyotype; ordinary miscarriage. The 
general cholesterol (GC) was determined by colorimetric and enzymatic method with esterase and 
oxidase of cholesterol (CHOD/PAP), triglycerides (TG) – by enzymatic colorimetric method using 
glycerophosphoric oxidase (GPO), high-density lipoproteins – HDL – were determined using the 
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diagnostic set of determination of HDL cholesterol concentration by homogenous method of direct 
determination of HDL-cholesterol concentration in the blood serum without preliminary process-
ing and centrifugation; low-density lipoproteins (LDL) were determined using diagnostic method 
for determination of LDL cholesterol concentration by the direct method. Very low-density proteins 
(VLDL) concentration was calculated by Friedewald formula: VLDL=TG/2,2. The calculation of ath-
erogenic index of plasma (AIP) was carried out, taking into account the levels of lipid parameters: 
AIP=Log TG/HDL-c, where TG and LHL concentration is expressed in mmol/l [8]. The calculation 
of the levels of cardiac risk (CR) was carried out by the formula: CR=TC/HDL-c [9]. The coefficient of 
atherogenicity (CA) was calculated by the following formula: CA=(TC-HDL-c)/HDL-c [10] (referent 
values – 2,2–3,5). Lactate concentration was determined using diagnostic set for determination of its 
concentration (referent value is 0,5–2,2 mmol/l) and LDH that was also determined using diagnostic 
set for LDH (LD) by optimized method, elaborated taking into account the recommendations of 
German Association of clinical chemistry (DGKC) (referent values 225–450 U/l) after correspondent 
calibration of automatic analyzer ACCENT-200 II GEN. Statistical processing of data was carried out 
using the package of applied programs Microsoft Office Excel 2010 and StatSoft Statistica 6.1 [11].
4. Results of research
In 43 (16,1 %) women of 267 examined pregnancy was complicated with the development of 
clinical signs of PE. Among them I group included 26 women with the development of PE clinical 
presentation of light degree; II group – 17 women with PE of middle severity. The other 224 women 
formed the control group (III group) without obstetric and somatic pathology with normal course 
of pregnancy without PE clinic, who were delivered in time mainly by the way of natural puerperal 
ways (Fig. 1). 
Fig. 1. Cases of pre-eclampsia (%) among women, examined during the II trimester of pregnancy 
Mean age of women (years) of I group was 31,03±0,67, II group – 28,24±0,68, III group – 
30,04±0,54. Body mass index (BMI) among examined groups of women was: 25,13±0,54 – in 
I group, comparing with control – 21,23±1,18 and 27,41±1,04 – in II group of women. 
The indices of systolic and diastolic pressure (mm of m. c.) in women with PE development 
reliably differed from the control group: in I group – 143,72±0,34 and 95,21±1,13 at mean values 
of daily proteinuria (g/day) – 0,154±1,23; in II group – 164,34±1,12 and 108,32±0,54 at indices 
3,96±1,34 g/day of proteinuria comparing with III group – 112,57± 1,76 and 69,13± 2,31 at absence 
of protein in urine. 
The percent of deliveries by the way of cesarean section was 42 % in the group of women 
with PE. 
The mean levels (mmol/l) of TG among all women with cases of PE development 
were – 1,79±0,16; HDL – 0,71±0,12; VLDL – 0,84±0,08 comparing with TG, HDL and VLDL levels 
among the women of control group that were respectively 1,51±0,06; 1,19±0,12 and 0,60±0,16 (p<0,05). 
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These disorders of lipid metabolism were especially brightly expressed in women, whose pregnan-
cy was complicated with the severe PE forms, that was testified by the received high indices of 
TG – 1,86±0,18 with decrease of HDL – 0,64±0,04 and increase of VLDL – 0,90±0,06 levels in 
II studied group of pregnant comparing with I main group and control group of women with physi-
ological course of pregnancy (p<0,05). At analysis of GC and LDL any significant differences were 
not observed between the women with PE development and control group. Among all women of 
control group were not observed any reliable differences in all indices of lipid profile of the blood 
serum during II trimester of pregnancy (p<0,001). 
In our research the mean indices of AIP in women with PE were for the I group – 0,34±0,12, 
whereas for II group of women with PE of middle severity – 0,46±0,18 at 0,10±0,23 in III group of 
physiological course of pregnancy (p<0,001). СR level for women with PE in I group – 6,21±0,08 at 
7,96±0,11 in II group and 3,95±0,19 in control, group(p<0,001). CA increase in 3,0 times was fixed 
among women of II group comparing with I and III groups of pregnant women (correspondingly 
2,1 and norm) (p<0,05). At the same time there was demonstrated the positive connection between 
AIP and the levels of maternal serumal TG and systolic and diastolic arterial pressure in women 
with PE development at absence of such connection among women of the control group (p<0,05), 
that is testified by the results of research by Kashinakunti et al., and Bennal et al. [16, 17].
The graphic expression of the data of atherogenic (cardiac) indices in three studied groups 
is presented on the Fig. 2–4.
Fig. 2. Cardiac indices in women with PE of light degree (the levels of coefficient of 
atherogenicity among 26 women of I group are expressed in ciphers)
Fig. 3. Cardiac indices in women with development of middle severe forms of PE (the values of 
coefficient of atherogenicity among 17 women of II group are expressed in ciphers) 
We also noted the gradual increase of cardiac glycolytic enzyme LDH, detected in the blood 
during the second trimester in women, which pregnancy was complicated with PE development, 
at the same time the association of this parameter especially with severe form of this pathology is 
important: for the women of I group LDH level was – 389±1,6 U/l at 778±0,25 in women of II group 
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and 265±0,19 in control group (p<0,05). At the same time the lactate level had no tendency to de-
crease and was within physiological norms (p<0,05).
Fig. 4. Cardiac indices in women at physiological course of pregnancy 
5. Discussion of the results of research 
Analyzing the received data it is important to note, that the women of the main group with 
clinical signs of PE were in the young reproductive age with normal weight that is indicated by the 
body mass index (BMI) in studied groups. 
At the analysis of indices that are responsible for the processes of initiation of atherogenesis 
were fixed the manifestations of dyslipoproteinemia among women with PE development mainly at 
the expense of hyperglyceridemia with gradual decrease of anti-atherogenic HDL and increase of 
atherogenic VLDL levels, fixed in the blood serum of pregnant during II gestation trimester. Taking 
into account the received indices of lipid profile of the blood, we calculated the modern atherogenic 
(cardiac) indices, which parameters can help doctors in prognostication of remote cardiometabolic 
pathology among this category of women with PE. Thus, according to the data of researches, AIP 
(“zone of arterial risk”) prognosticates cardio-vascular risks and is considered as easily accessible 
marker of cardio-vascular pathology and is useful for determination of adequate pharmacological 
therapy that must not be higher than 0, 24 [12, 13]. According to the data of NCEP ATP III [14] the 
use of the level of cardiac risk (СR) can be considered as a powerful predictor of cardio-vascular 
risks that must not exceed 5 (optimal values of index-3,5) [15]. Analyzing the received data, we 
can state that in women, whose pregnancy was complicated with the development of PE clinical 
presentation the levels of all atherogenic indices were significantly higher. 
At the same time, from our point of view, the increase of LDH level in this category can 
indicate the initial stages of injury of membranes of endothelial cells and increased permeability 
of cells for the injuring factors with activation at the beginning of compensatory possibilities of 
cells and their loss that is finally manifested by LDH emission in extracellular space and starting 
of cascade of biochemical reactions, which result is the development of endothelial dysfunction 
and finally clinical signs, typical for PE. Taking into account the literary sources, in women with 
PE development the progressive endothelial dysfunction in maternal vascular system, induced by 
toxic substances, released from hypoxic placenta, is a cause of deep vasoconstriction that injures 
practically all organs and systems, including liver. This hypoperfusion induces the ischemic injury 
of hepatic cells and other organs, causing the raised release of intracellular LHD in circulation 
channel [18–20]. At the same time the aforesaid progressive increase of LDH level in the case of PE 
severe forms indicates the progressing of injury of endothelium cells with the degree of severity of 
disease. It must be noted that in women with the development of middle severe forms of PE on the 
background of hypertriglyceridemia the atherogenic indices and LDH level progressively increase 
that can testify to the high risks of development of cardio-vascular and metabolic pathology in 
nearest years after delivery. This category of women is recommended to observe accurately the 
all prophylactic arrangements, directed on correction of hyperlipidemic states, taking into account 
BMI, programs of dietary nutrition and dosed physical load with obligatory biochemical control of 
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lipid profile of the blood serum under the supervision of endocrinologist and cardiologist and with 
adequate medicamentous therapy. 
6. Conclusions
1. Dyslipoproteinemia is a risk factor and predicator as to the development of PE and its re-
mote cardio-vascular and metabolic complications mainly at the expense of hypertriglyceridemia, 
fixed in pregnant during the second gestational trimester. 
2. The progressing increase of the levels of atherogenic (cardiac) indices in women with 
PE, especially in the case of its middle severe forms can indicate the high risks of development of 
different cardio-vascular pathology in this category of women in nearest years after delivery. 
3. The progressing increase of LDH level already since the second trimester of pregnancy is 
typical for women, whose pregnancy was complicated with the development of severe forms of PE 
that on the background of hypertriglyceridemic state and in correspondence with growing athero-
genic indices can be the early predicator of the development of severe cardiometabolic pathology. 
4. The category of women with pregnancy course, complicated with severe forms of PE 
is recommended to undergo the early biochemical screening as to the possible development of 
cardio-vascular pathology under prophylactic and medicamentous control of endocrinologist and 
cardiologist. 
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